Updates & Innovations Summer 2011
Throughout Southeast Michigan, extending from beyond Novi to the thumb, the St. John Providence Stroke Network is a unique, interconnected team capable of providing high-tech care at multiple, far-reaching sites. Taking advantage of technology, St. John Providence Health System (SJPHS) offers acute stroke care and advanced stroke management for new patients and transfers from any hospital, including those from outside SJPHS.
SJPHS gastroenterologists (GI) and the GI fellowship program, one of the largest community teaching programs in Michigan for gastroenterology, are taking the lead in the treatment of esophageal diseases. Gastroesophageal reflux (GERD) has steadily grown in prevalence in the US. Presently, one-third of the population suffers from reflux symptoms at least once per month. Ten percent suffer with significant reflux symptoms up to three or more times per week.
For pediatric and adult patients with craniofacial disorders including congenital deformities, tumors of the head/neck/skull base, facial trauma and other diseases, the Craniofacial Institute provides multi-disciplinary services that are among the highest quality and most innovative in the world.
St. John Providence Health System (SJPHS) offers cutting-edge rehabilitative medicine, and when needed, has one of the largest orthopedic programs in the country with two orthopedic residencies. For patients with unresolved tendon and ligament injury, two in-office procedures, prolotherapy and platelet-rich plasma (PRP) injections, offer significant results without surgery. These treatments work similarly to increase blood flow to injury areas and jump-start healing.
Gastroesophageal reflux disease (GERD) affects 35 percent of the population. When symptoms occur more than twice a week and lifestyle is affected, medical treatment is indicated. When over-the-counter or prescribed medicines are not completely effective, surgical options are available.
After a two-day retreat held at the beginning of 2011 and sponsored by St. John HealthPartners, physicians and St. John Providence Health System (SJPHS) leadership have taken significant steps forward on the Accountable Care Organization (ACO) development path. Since the retreat, and through the guidance of Bill Thompson, a consultant with experience working with physician-hospital organizations, the Physician Alliance and SJPHS leadership has:
Ascension Health approved $7.3 million to support the renovation and reconfiguration of the inpatient facilities at St. John Macomb-Oakland Hospital, Macomb Center which is the home of the nation's largest osteopathic training program. This project involves the renovation of the Macomb campus by adding 46 beds. Of those beds, 30 will be used for observation patients and 16 will be medical/surgical beds located throughout the facility. Administration, Pharmacy, Worklife Services, Cardiac Rehab, and Nursing Administration will be relocated into other areas, mainly the Medical Office Building.
Sleep Disorders are treated through the St. John Providence Health System (SJPHS) Sleep Disorders Centers. While sleep disorders are common in the adult population, disordered sleep is a growing concern among older adults, affecting 10 to 33 percent of older Americans.
Symphony is a significant initiative across all of Ascension Health (including SJPHS) that will standardize and introduce new business processes in Finance, Worklife Services, and Supply Chain over the next three years. Installation of Symphony will replace a number of the existing systems and processes we currently use within SJPHS.
Our major teaching hospitals this spring held their Annual Research Day activities with dozens of innovative research projects and case reports presented for critique by regional judges. In addition, our top projects competed at the Southeast Michigan Center for Medical Education Research Forum held at Meadowbrook on May 18, 2011. Dr. Jasneet Singh Bhullar, MD from Providence Hospital and Medical Center was honored with the first place award for the project “Effects of Intraluminal Chemotherapy on Colorectal Cancer in an Orthotopic Murine Model.”